Support Alert

Class 2 medicines recall: Pharmaram Ltd, Clexane 4,000 IU (40mg)/0.4ml syringes

Pharmaram Ltd has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that a specific batch of Clexane 4,000IU (40mg)/0.4ml syringes has an error on the labelling affixed to the plastic blister packaging encasing the syringe.

The label incorrectly states “Clexane 6,000IU (60mg)/0.6ml Syringes”, when it should have stated “Clexane 4,000IU (40mg)/0.4ml Syringes”. The outer carton states the correct strength; the batch number and expiry dates are also correct and match the details on the labelling.

Further information including details of the affected batch and advice for healthcare professionals can be found on the MHRA website.


Renew for 2022

Your dedication to patient care has made us proud during 2021.

That's why you can count on us to represent your interests and support your efforts every step of the way in 2022.